Literature Database for Quercetin, Rutin, Isorhamnetin, and Their Related Compounds

Here we provide a literature database for flavonoids, focused upon quercetin, rutin, isorhamnetin, and their related compounds. Original papers and reviews about in vitro, in vivo, and clinical pharmacologies are contained here.

Search

Result:: 11-20 Hits of 38

Novel targeted delivery of quercetin for human hepatocellular carcinoma using starch/polyvinyl alcohol nanocarriers based hydrogel containing Fe2O3 nanoparticles

Authors:: Afsaneh Mojtahedzadeh Asl; Mohammad Reza Kalaee; Majid Abdouss; Seyed Saied Homami

Reference:: International Journal of Biological Macromolecules; 2024; 257; 128626

DOI:: 10.1016/j.ijbiomac.2023.128626

See Abstract

Quercetin/Anti-PD-1 Antibody Combination Therapy Regulates the Gut Microbiota, Impacts Macrophage Immunity and Reshapes the Hepatocellular Carcinoma Tumor Microenvironment

Authors:: Ruoxia Wu; Jiaqing Xiong; Ting Zhou; Zhen Zhang; Zhen Huang; Sha Tian; Yongli Wang

Reference:: Frontiers in Bioscience-Landmark; 2023; 28; 327

DOI:: 10.31083/j.fbl2812327

See Abstract

Radix Bupleuri-Radix Paeoniae Alba Inhibits the Development of Hepatocellular Carcinoma through Activation of the PTEN/PD-L1 Axis within the Immune Microenvironment

Authors:: Fan Zhang; Kun Zhou; Wei Yuan; Kewei Sun

Reference:: Nutrition and Cancer; 2024; 76; 63-79

DOI:: 10.1080/01635581.2023.2276525

See Abstract

Dietary antioxidant quercetin overcomes the acquired resistance of Sorafenib in Sorafenib-resistant hepatocellular carcinoma cells through epidermal growth factor receptor signaling inactivation

Authors:: Zhengguang Zhang; Haitao Wu; Yajie Zhang; Cunsi Shen; Fuqiong Zhou

Reference:: Naunyn-Schmiedeberg's Archives of Pharmacology; 2024; 397; 559–574

DOI:: 10.1007/s00210-023-02605-3

See Abstract

Isorhamnetin and anti-PD-L1 antibody dual-functional mesoporous silica nanoparticles improve tumor immune microenvironment and inhibit YY1-mediated tumor progression

Authors:: Huijuan Liu; Jingxia Han; Ying Lv; Zihan Zhao; Shaoting Zheng; Yu Sun; Tao Sun

Reference:: Journal of Nanobiotechnology; 2023; 21; 208

DOI:: 10.1186/s12951-023-01967-3

See Abstract

Quercetin shows anti-tumor effect in hepatocellular carcinoma LM3 cells by abrogating JAK2/STAT3 signaling pathway

Authors:: Liwei Wu; Jingjing Li; Tong Liu; Sainan Li; Jiao Feng; Qiang Yu; Jie Zhang; Jiaojiao Chen; Yuting Zhou; Jie Ji; Kan Chen; Yuqing Mao; Fan Wang; Weiqi Dai; Xiaoming Fan; Jianye Wu; Chuanyong Guo

Reference:: Cancer Medicine; 2019; 8; 4806-4820

DOI:: 10.1002/cam4.2388

See Abstract

New Approach for Treatment of Primary Liver Tumors: The Role of Quercetin

Authors:: Ana Filipa Brito; Marina Ribeiro; Ana Margarida Abrantes; Ana Catarina Mamede; Mafalda Laranjo; João Eduardo Casalta-Lopes; Ana Cristina Gonçalves; Ana Bela Sarmento-Ribeiro; José Guilherme Tralhão; Maria Filomena Botelho

Reference:: Nutrition and Cancer; 2016; 68; 250-266

DOI:: 10.1080/01635581.2016.1145245

See Abstract

Isorhamnetin exerts anti-tumor activity in DEN + CCl4-induced HCC mice

Authors:: Sayanta Sarkar; Abhishek Kumar Das; Semantee Bhattacharya; Ratan Gachhui; Parames C. Sil

Reference:: Medical Oncology; 2023; 40; 188

DOI:: 10.1007/s12032-023-02050-5

See Abstract

Quercetin, the Ingredient of Xihuang Pills, Inhibits Hepatocellular Carcinoma by Regulating Autophagy and Macrophage Polarization

Authors:: Ruoxia Wu; Ting Zhou; Jiaqing Xiong; Zhen Zhang; Sha Tian; Yongli Wang; Jindong Chen; Xuefei Tian

Reference:: Frontiers in Bioscience-Landmark; 2022; 27; 323

DOI:: 10.31083/j.fbl2712323

See Abstract

Rutin-loaded Phyto-Sterosomes as a potential approach for the treatment of hepatocellular carcinoma: In-vitro and in-vivo studies

Authors:: Mona M. AbouSamra; Sherif M. Afifi; Asmaa F. Galal; Rabab Kamel

Reference:: Journal of Drug Delivery Science and Technology; 2023; 79; 104015

DOI:: 10.1016/j.jddst.2022.104015

See Abstract